06833 SINCO PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.18X | Oper Margin | 3.9% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 1.7% |
| Total Debt/Equity | 26.4% | Return on Equity | 5.0% |
| Price/Book | 0.49X | Return on Assets | 1.9% |
| (HKD 0.185) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 38.79 | 44.71 | 46.68 | 77.88 | 165.22 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -13.2 | -4.2 | -40.1 | -52.9 | +17.8 |
| Earnings Per Share (HKD) | 0.019 | 0.022 | 0.023 | 0.038 | 0.095 |
| Earnings Per Share Growth (%) | -13.2 | -4.4 | -40.0 | -59.7 | +14.7 |
| Dividend Per Share (HKD) | 0.002 | 0.002 | 0.004 | 0.010 | No dividend |
| P/E* (X) | 9.69 | 8.41 | 8.04 | 4.83 | 1.95 |
| Yield (%) | 0.90 | 1.08 | 2.11 | 5.30 | N/A |
| Dividend Share (%) | 8.90 | 9.09 | 16.96 | 25.59 | N/A |
| Book NAV (HKD) | 0.380 | 0.347 | 0.341 | 0.333 | 0.245 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 2,085 | 2,821 | -26.1 | 2,540 |
| Operating Result | 48.259 | 98.92 | -51.2 | 99.845 |
| Profit Before Taxation | 48.259 | 98.92 | -51.2 | 99.881 |
| Taxation | 13.407 | 56.875 | -76.4 | 57.529 |
| Profit /( Loss) After Taxation | 34.852 | 42.045 | -17.1 | 42.352 |
| Net Profit | 34.852 | 42.045 | -17.1 | 42.352 |
| Earnings Per Share () | 0.0191 | 0.0220 | -13.2 | 0.0230 |
| Dividend Per Share () | 0.0017 | 0.0020 | -15.0 | 0.0039 |
| Announcement Date | 2026-03-26 | 2025-03-28 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
